Burning Rock Biotech (BNR) Other Non-Current Assets (2021 - 2023)

Burning Rock Biotech has reported Other Non-Current Assets over the past 3 years, most recently at $706659.0 for Q4 2023.

  • Quarterly results put Other Non-Current Assets at $706659.0 for Q4 2023, down 51.33% from a year ago — trailing twelve months through Dec 2023 was $706659.0 (down 51.33% YoY), and the annual figure for FY2023 was $718000.0, down 53.31%.
  • Other Non-Current Assets for Q4 2023 was $706659.0 at Burning Rock Biotech, down from $1.5 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for BNR hit a ceiling of $7.1 million in Q4 2021 and a floor of $706659.0 in Q4 2023.
  • Median Other Non-Current Assets over the past 3 years was $1.5 million (2022), compared with a mean of $3.1 million.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 79.43% in 2022 and later tumbled 51.33% in 2023.
  • Burning Rock Biotech's Other Non-Current Assets stood at $7.1 million in 2021, then plummeted by 79.43% to $1.5 million in 2022, then crashed by 51.33% to $706659.0 in 2023.
  • The last three reported values for Other Non-Current Assets were $706659.0 (Q4 2023), $1.5 million (Q4 2022), and $7.1 million (Q4 2021) per Business Quant data.